Obesity And Obstetric Anesthesia: Current Insights

Cameron R Taylor1, Jennifer E Dominguez1, Ashraf S Habib1

  • 1Department of Anesthesiology, Division of Women's Anesthesia, Duke University, Durham, NC 27710, USA.

Insights

Obesity in pregnancy presents significant anesthetic challenges, increasing risks for mothers and newborns. Careful anesthetic planning and management are crucial for optimizing outcomes in obese parturients undergoing cesarean delivery.

Area of Science:

  • Anesthesiology
  • Obstetrics
  • Public Health

Background:

  • Obesity is a major global health issue with significant implications for pregnancy.
  • Obese pregnant women face increased risks of complications for themselves and their neonates, including higher rates of cesarean delivery.
  • Comorbidities like obstructive sleep apnea are common, requiring specialized antepartum anesthetic consultations.

Purpose of the Study:

  • To highlight the unique anesthetic challenges posed by obese parturients.
  • To discuss strategies for optimizing anesthetic care in this population.
  • To review anesthetic techniques and management considerations for cesarean delivery in obese women.

Main Methods:

  • Review of anesthetic considerations for obese parturients.
  • Discussion of neuraxial anesthesia techniques (epidural, combined spinal-epidural) for cesarean delivery.
  • Consideration of monitoring, positioning, and post-operative care.

Main Results:

  • Neuraxial anesthesia is preferred for cesarean delivery in obese patients to mitigate risks associated with general anesthesia.
  • Challenges in neuraxial placement exist but can be overcome with techniques like functional labor epidural top-up or combined spinal-epidural.
  • Post-operative care must address thromboembolism risk and close monitoring for complications.

Conclusions:

  • Obese parturients require specialized anesthetic management due to increased risks and unique challenges.
  • Neuraxial anesthesia is generally preferred for cesarean delivery, with specific techniques to facilitate placement and efficacy.
  • Comprehensive management, including pre-delivery optimization, intraoperative care, and post-partum monitoring, is essential.

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
173
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
202
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
136
Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
649
General Anesthesia: Overview01:24

General Anesthesia: Overview

Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
523